A detailed history of Fidelity D & D Bancorp Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Fidelity D & D Bancorp Inc holds 325 shares of LLY stock, worth $249,522. This represents 0.19% of its overall portfolio holdings.

Number of Shares
325
Previous 345 5.8%
Holding current value
$249,522
Previous $312 Million 7.82%
% of portfolio
0.19%
Previous 0.24%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 06, 2024

SELL
$772.14 - $960.02 $15,442 - $19,200
-20 Reduced 5.8%
325 $288 Million
Q1 2024

Apr 16, 2024

SELL
$592.2 - $792.28 $29,610 - $39,614
-50 Reduced 12.66%
345 $268 Million
Q4 2023

Jan 12, 2024

BUY
$525.19 - $619.13 $207,450 - $244,556
395 New
395 $230 Million
Q1 2023

Apr 16, 2024

SELL
$310.63 - $364.82 $15,531 - $18,241
-50 Reduced 12.66%
345 $268 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Fidelity D & D Bancorp Inc Portfolio

Follow Fidelity D & D Bancorp Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fidelity D & D Bancorp Inc, based on Form 13F filings with the SEC.

News

Stay updated on Fidelity D & D Bancorp Inc with notifications on news.